BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15160935)

  • 1. Breast cancer resistance protein (BCRP) in acute leukemia.
    Plasschaert SL; Van Der Kolk DM; De Bont ES; Vellenga E; Kamps WA; De Vries EG
    Leuk Lymphoma; 2004 Apr; 45(4):649-54. PubMed ID: 15160935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mechanisms of drug resistance in leukemia.
    Ross DD
    Leukemia; 2000 Mar; 14(3):467-73. PubMed ID: 10720143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of drug efflux pumps in acute myeloid leukemia.
    van der Kolk DM; de Vries EG; Müller M; Vellenga E
    Leuk Lymphoma; 2002 Apr; 43(4):685-701. PubMed ID: 12153153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the breast cancer resistance protein (ABCG2) in drug transport.
    Mao Q; Unadkat JD
    AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).
    Ni Z; Bikadi Z; Rosenberg MF; Mao Q
    Curr Drug Metab; 2010 Sep; 11(7):603-17. PubMed ID: 20812902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-resistant proteins in breast cancer: recent progress in multidrug resistance].
    Wu DL; Huang F; Lu HZ
    Ai Zheng; 2003 Apr; 22(4):441-4. PubMed ID: 12704006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells.
    Brooks TA; O'Loughlin KL; Minderman H; Bundy BN; Ford LA; Vredenburg MR; Bernacki RJ; Priebe W; Baer MR
    Invest New Drugs; 2007 Apr; 25(2):115-22. PubMed ID: 17072745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L; Ross DD
    Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA.
    Grundy M; Seedhouse C; Russell NH; Pallis M
    BMC Cancer; 2011 Jun; 11():254. PubMed ID: 21679421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.
    Minderman H; O'Loughlin KL; Pendyala L; Baer MR
    Clin Cancer Res; 2004 Mar; 10(5):1826-34. PubMed ID: 15014037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.
    Nakanishi T; Ross DD
    Chin J Cancer; 2012 Feb; 31(2):73-99. PubMed ID: 22098950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function.
    Suvannasankha A; Minderman H; O'Loughlin KL; Nakanishi T; Greco WR; Ross DD; Baer MR
    Leukemia; 2004 Jul; 18(7):1252-7. PubMed ID: 15208643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors.
    Lemos C; Jansen G; Peters GJ
    Br J Cancer; 2008 Mar; 98(5):857-62. PubMed ID: 18253130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
    van der Pol MA; Broxterman HJ; Pater JM; Feller N; van der Maas M; Weijers GW; Scheffer GL; Allen JD; Scheper RJ; van Loevezijn A; Ossenkoppele GJ; Schuurhuis GJ
    Haematologica; 2003 Feb; 88(2):134-47. PubMed ID: 12604403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A is a broad-spectrum multidrug resistance modulator.
    Qadir M; O'Loughlin KL; Fricke SM; Williamson NA; Greco WR; Minderman H; Baer MR
    Clin Cancer Res; 2005 Mar; 11(6):2320-6. PubMed ID: 15788683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
    Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines.
    Scheffer GL; Maliepaard M; Pijnenborg AC; van Gastelen MA; de Jong MC; Schroeijers AB; van der Kolk DM; Allen JD; Ross DD; van der Valk P; Dalton WS; Schellens JH; Scheper RJ
    Cancer Res; 2000 May; 60(10):2589-93. PubMed ID: 10825126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia.
    Raaijmakers MH; de Grouw EP; Heuver LH; van der Reijden BA; Jansen JH; Scheper RJ; Scheffer GL; de Witte TJ; Raymakers RA
    Clin Cancer Res; 2005 Mar; 11(6):2436-44. PubMed ID: 15788695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance and cancer: the role of the human ABC transporter ABCG2.
    Ejendal KF; Hrycyna CA
    Curr Protein Pept Sci; 2002 Oct; 3(5):503-11. PubMed ID: 12369998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
    van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P
    Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.